Goey, S.H.

patient cancer interleukin interleukin -2 study treatment response tumor cell carcinoma metastatic chapter effect toxicity cycle phase carcinoma therapy lymphocytes activity il -2 level interferon immunotherapy combination 5- fu catheter administration infusion killer antibody cytokine hepatic rosenberg disease trial phase ii study oncol month artery intrapleural cell cancer colorectal cancer result colorectal melanoma killer cells hepatic artery response rates rosenberg sa infection range factor table high-dose tumour group iymphokine-activated killer cells receptor randomized ifn-a mesothelioma survival antigen t-cell stoter antitumor tumor cells response rate immunol schedule metastase side effects metastatic melanoma blood liver regimen -2. activation murine phase i study